The antinociceptive effect of Δ9-tetrahydrocannabinol in the arthritic rat involves the CB2 cannabinoid receptor

European Journal of Pharmacology

Volumn 570, Issue 1-3, 2007, Pages 50-56

  Cox, Melinda L ^a   Haller, Victoria L ^a   Welch, Sandra P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Arthritis; Cannabinoid; CB1 receptor; CB2 receptor; SR141716A; SR144528

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DRONABINOL; RIMONABANT; ANALGESIC AGENT; BORNANE DERIVATIVE; CANNABINOID RECEPTOR CB2, RAT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTHRITIS; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; MESENCEPHALON; METABOLISM; PAIN; SPINAL CORD;

ANALGESICS; ANIMALS; ARTHRITIS, EXPERIMENTAL; BORNANES; MALE; MESENCEPHALON; PAIN; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SPINAL CORD; TETRAHYDROCANNABINOL;

EID: 34547837599     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.05.024     Document Type: Article

References (40)

1. Anikwue R., Huffman J.W., Martin Z.L., and Welch S.P. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta (9)-tetrahydrocannabinol administration. J. Pharmacol. Exp. Ther. 303 1 (2002) 340-346
2. Ballet S., Mauborgne A., Benoliel J.J., Bourgoin S., Hamon M., Cesselin F., and Collin E. Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat. Brain Res. 796 (1998) 198-208
3. Ballet S., Mauborgne A., Hamon M., Cesselin F., and Collin E. Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats. Synapse 37 (2000) 262-272
4. Calignano A., La Rana G., Giuffrida A., and Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 394 (1998) 277-281
5. Cox M.L., and Welch S.P. The antinociceptive effect of delta 9-tetrahydrocannabinol in the arthritic rat. Eur. J. Pharmacol. 493 (2004) 65-74
6. Elmes S.J., Jhaveri M.D., Smart D., Kendall D.A., and Chapman V. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur. J. Neurosci. 20 (2004) 2311-2320
7. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., and Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3376-3380
8. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., and Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232 (1995) 54-61
9. Griffin G., Fernando S.R., Ross R.A., Mckay N.G., Ashford M.L., Shire D., Huffman J.W., Yu S., Lainton J.A., and Pertwee R.G. Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur. J. Pharmacol. 339 (1997) 53-61
10. Haller V.L., Cichewicz D.L., and Welch S.P. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. Eur. J. Pharmamcol. 546 (2006) 60-68
11. Hanus L., Breuer A., Tchilibon S., Shiloah S., Goldenberg D., Horowitz M., Pertwee R.G., Ross R.A., Mechoulam R., and Fride E. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14228-14233
12. Hohmann A.G., Farthing J.N., Zvonok A.M., and Makriyannis A. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. J. Pharmacol. Exp. Ther. 308 (2004) 446-453
13. Hohmann A.G., Neely M.H., Piña J., and Nackley A.G. Neonatal chronic hind paw inflammation alters sensitization to intradermal apsaicin in adult rats: a behavioral and immunocytochemical study. J. Pain. 6 12 (2005) 798-808
14. Ibrahim M.M., Deng H., Zvonok A., Cockayne D.A., Kwan J., Mata H.P., Vanderah T.W., Lai J., Porreca F., Makriyannis A., and Malan Jr. T.P. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10529-10533
15. Kawasaki Y., Kohno T., and Ji R.R. Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats. J. Pharmacol. Exp. Ther. 316 2 (2006) 601-607
16. Lichtman A.H., and Martin B.R. Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258 2 (1991) 517-523
17. Malan Jr. T.P., Ibrahim M.M., Deng H., Liu Q., Mata H.P., Vanderah T., Porreca F., and Makriyannis A. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93 (2001) 239-245
18. Malan Jr. T.P., Ibrahim M.M., Vanderah T.W., Makriyannis A., and Porreca F. Inhibition of pain responses by activation of CB(2) cannabinoid receptors. Chem. Phys. Lipids 121 (2002) 191-200
19. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (London) 346 (1990) 561-564
20. Mazzari S., Canella R., Petrelli L., Marcolongo G., and Leon A. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol. 300 (1996) 227-236
21. Millan M.J., Millan M.H., Czlonkowski A., Höllt V., Pilcher C.W., Herz A., and Colpaert F.C. A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis. J. Neurosci 6 (1986) 899-906
22. Millan M.J., Millan M.H., Czlonkowski A., Höllt V., Pilcher C.W., Herz A., and Colpaert F.C. Functional response of multiple opioid systems to chronic arthritic pain in the rat. Ann. N. Y. Acad. Sci. 467 (1986) 182-193
23. Mao J., Price D.D., Lu J., Keniston L., and Mayer D.J. Two distinctive antinociceptive systems in rats with pathological pain. Neurosci. Lett. 280 1 (2000) 13-16
24. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature (London) 365 (1993) 61-64
25. Pohl M., Ballet S., Collin E., Mauborgne A., Bourgoin S., Benoliel J.J., Hamon M., and Cesselin F. Enkephalinergic and dynorphinergic neurons in the spinal cord and dorsal root ganglia of the polyarthritic rat. In vivo release and cDNA hybridization studies. Brain Res. 749 (1997) 18-28
26. Quartilho A., Mata H.P., Ibrahim M.M., Vanderah T.W., Porreca F., Makriyannis A., and Malan Jr. T.P. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99 4 (2003) 955-960
27. Randall L.O., and Sellito J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 111 (1957) 409-419
28. Richardson J.D. Cannabinoids modulate pain by multiple mechanisms of action. J. Pain 1 (2000) 2-14
29. Ross R.A., Coutts A.A., Mcfarlane S.M., Anavi-Goffer S., Irving A.J., Pertwee R.G., Macewan D.J., and Scott R.H. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology 40 (2001) 221-232
30. Scott D.A., Wright C.E., and Angus J.A. Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Pain 109 (2004) 124-131
31. Smith F.L., Fujimori K., Lowe J., and Welch S.P. Characterization of (9-tetrahydrocannabinol and anandamide antinociception in NA and arthritic rats. Pharmacol. Biochem. Behav. 60 (1998) 183-191
32. Sofia R.D., Nalepa S.D., Harakal J.J., and Vassar H.B. Anti-edema and analgesic properties of (9-tetrahydrocannabinol (THC). J. Pharmacol. Exp. Ther. 186 (1973) 646-655
33. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., and Ishima Y. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 274 5 (1999) 2794-2801
34. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., and Waku K. Evidence that 2-archidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275 1 (2000) 605-612
35. Tallarida R.J., and Murray R.B. Manual of Pharmacologic Calculations with Computer Programs (1987), Springer-Verlag, New York
36. Tanda G., and Goldberg S.R. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology (Berl) 169 2 (2003) 115-134
37. Valenzano K.J., Tafesse L., Lee G., Harrison J.E., Boulet J.M., Gottshall S., Mark L., Pearson M.S., Miller W., Shan S., Rabadi L., Rotshteyn Y., Chaffer S.M., Turchin P.I., Elsemore D.A., Toth M., Koetzner L., and Whiteside G.T. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Neuropharmacology 48 5 (2005) 658-672
38. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman O.J., Patel K.D., and Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 5746 (2005) 329-332
39. Wotherspoon G., Fox A., McIntyre P., Colley S., Bevan S., and Winter J. Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience 135 1 (2005) 235-245
40. Zhang J., Hoffert C., Vu H.K., Groblewski T., Ahmed S., and O'Donnell D. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur. J. Neurosci. 17 (2003) 2750-2754